CapsoVision director gets 358,344 stock options

CapsoVision, Inc director and officer Wang Kang-Huai received a grant of stock options covering 358,344 shares of common stock at an exercise price of $6.90 per share.

Rhea-AI Filing Summary

CapsoVision, Inc director and officer Wang Kang-Huai received a grant of stock options covering 358,344 shares of common stock at an exercise price of $6.90 per share. The options were granted at no cost and expire on June 1, 2036.

The grant vests as to 25% of the options on June 1, 2027, with the remaining 75% vesting in 36 equal monthly installments through June 1, 2030, subject to continued service. Following this award, Wang holds 629,304 derivative securities directly.

Insider Trade Summary

Grant/Award: 358,344 shares

Grant/Award 1 txn

Insider Wang Kang-Huai

Role See Remarks

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (right to buy)	358,344	$0.00	$0.00

Holdings After Transaction: Stock Option (right to buy) — 629,304 contracts (Direct)

Footnotes (1)

1. F1. The options vest as to 25% of the shares subject to the option on June 1, 2027 and as to the remaining 75% of the shares in 36 equal monthly installments thereafter through June 1, 2030, subject to continued service to the Issuer on each such date.

Key Figures

Options granted: 358,344 options Exercise price: $6.90 per share Expiration date: June 1, 2036 +3 more

6 metrics

Options granted 358,344 options Stock Option (right to buy) grant on June 1, 2026

Exercise price $6.90 per share Conversion or exercise price for the stock options

Expiration date June 1, 2036 Option expiration date

Holdings after grant 629,304 derivative securities Total derivative securities following transaction

Initial vesting tranche 25% of options Vests on June 1, 2027

Remaining vesting period 75% over 36 months Monthly vesting through June 1, 2030

Key Terms

Stock Option (right to buy), exercise price, expiration date, vesting

4 terms

Stock Option (right to buy) financial

"security_title: "Stock Option (right to buy)""

exercise price financial

"conversion_or_exercise_price": "6.9000""

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

expiration date financial

"expiration_date": "2036-06-01T00:00:00.000Z""

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

vesting financial

"The options vest as to 25% of the shares subject to the option"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did CapsoVision (CV) report for Wang Kang-Huai?

CapsoVision reported a grant of stock options to director and officer Wang Kang-Huai. He received options for 358,344 shares of common stock as compensation, rather than making an open-market purchase or sale of existing CapsoVision shares.

How many CapsoVision (CV) stock options were granted and at what price?

Wang Kang-Huai was granted 358,344 CapsoVision stock options. Each option has an exercise price of $6.90 per share, meaning he can buy CapsoVision common stock at that price when the options vest and are exercised, subject to the vesting schedule.

What is the vesting schedule for Wang Kang-Huai’s CapsoVision (CV) options?

The options vest 25% on June 1, 2027. The remaining 75% then vest in 36 equal monthly installments through June 1, 2030, and each vesting date requires Wang’s continued service to CapsoVision to receive those additional shares.

When do Wang Kang-Huai’s CapsoVision (CV) stock options expire?

The granted CapsoVision stock options expire on June 1, 2036. After that date, any unexercised options become worthless, so the practical window to benefit from the $6.90 exercise price runs from vesting dates up to this expiration.

How many CapsoVision (CV) derivative securities does Wang hold after this grant?

After this option grant, Wang Kang-Huai directly holds 629,304 derivative securities. This total reflects his stock option holdings reported in the filing, showing his overall option-based exposure to CapsoVision common stock following the new award.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/03/2026 - 02:16 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wang Kang-Huai

(Last) (First) (Middle)

C/O CAPSOVISION, INC.

18805 COX AVENUE, SUITE 250

(Street)

SARATOGA CALIFORNIA 95070

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CapsoVision, Inc [ CV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$6.9	06/01/2026		A		358,344		(1)	06/01/2036	Common Stock	358,344	$0	629,304	D

Explanation of Responses:

1. The options vest as to 25% of the shares subject to the option on June 1, 2027 and as to the remaining 75% of the shares in 36 equal monthly installments thereafter through June 1, 2030, subject to continued service to the Issuer on each such date.

Remarks:

President and Chief Executive Officer

	/s/ Kang-Huai (Johnny) Wang	06/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)